Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) issued an announcement that the Group has obtained the drug production registration approval for latemovir injection (12ml: 240mg) from the China National Drug Administration. It is a Class 4 chemical drug, which is considered to have passed the consistency evaluation.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) issued an announcement that the Group has obtained the drug production registration approval for latemovir injection (12ml: 240mg) from the China National Drug Administration. It is a Class 4 chemical drug, which is considered to have passed the consistency evaluation.